Caxton Associates (New York)’s Aterian ATER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,333
Closed -$472K 471
2021
Q1
$472K Buy
+1,333
New +$513K 0.04% 172

Other funds holding ATER

Caxton Associates (New York)'s ATER Position: Q2 2021 in Review

Caxton Associates (New York) sold out of Aterian (ATER) in Q2 2021, closing a stake of 1,333 shares — an estimated $472K sold.

Caxton Associates (New York) first reported a position in ATER in Q1 2021 and held it in 1 quarter. The position peaked at $472K in Q1 2021. 82 funds tracked by Wall St. Rank hold ATER as of Q2 2021.

  • Caxton Associates (New York) reported no remaining Aterian position as of Q2 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 1,333 Aterian shares in Q2 2021, an estimated $472K.
  • Caxton Associates (New York) first reported a position in Aterian in Q1 2021 and held it in 1 quarter.
  • Caxton Associates (New York)'s Aterian position peaked at $472K in Q1 2021.
  • 82 funds tracked by Wall St. Rank held Aterian as of Q2 2021.

Based on Caxton Associates (New York)'s 13F filing for Q2 2021, filed 16 Aug 2021.